Clinical Trials
5
Active:1
Completed:3
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (50.0%)Phase 1
1 (25.0%)Phase 2
1 (25.0%)Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase
Phase 2
Recruiting
- Conditions
- Systemic InflammationCardiopulmonary-bypass
- Interventions
- Drug: RESCAP®Drug: placebo
- First Posted Date
- 2017-02-13
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Alloksys Life Sciences B.V.
- Target Recruit Count
- 1250
- Registration Number
- NCT03050476
- Locations
- 🇦🇺
Dept. Cardiothoracic Surgery , Monash Medical Centre, Clayton, Melbourne, Australia
🇦🇹Division of Cardiac Surgery, Department of Surgery, LKH Medical University of Graz, Graz, Austria
🇦🇹MedUniWien / AKH-Wien, Wien, Austria
Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis
Phase 1
Completed
- Conditions
- Acute Rheumatoid Arthritis
- Interventions
- Drug: s.c. injections of bovine intestinal Alkaline Phosphatase
- First Posted Date
- 2011-08-15
- Last Posted Date
- 2015-03-10
- Lead Sponsor
- Alloksys Life Sciences B.V.
- Target Recruit Count
- 6
- Registration Number
- NCT01416493
- Locations
- 🇬🇧
Maidstone Hospital, Dept. Rheumatology, Maidstone, Kent, United Kingdom
Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery
Phase 3
Completed
- Conditions
- Inflammation
- Interventions
- Drug: bIAP bolus and 8h infusionDrug: placebo bolus and 8h infusion
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Alloksys Life Sciences B.V.
- Target Recruit Count
- 53
- Registration Number
- NCT01144611
- Locations
- 🇳🇱
Catharina Ziekenhuis, Dept. CardioThoracic Surgery, Eindhoven, Netherlands
News
No news found